These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme. Broliden K, Abreu ER, Arneborn M, Böttiger M. Vaccine; 1998; 16(2-3):323-7. PubMed ID: 9607050 [Abstract] [Full Text] [Related]
27. Immunity to measles before and after MMR booster or primary vaccination at 12 years of age in the first generation offered the 2-dose immunization programme. Broliden K, Levén B, Arneborn M, Böttiger M. Scand J Infect Dis; 1998 Jan; 30(1):23-7. PubMed ID: 9670354 [Abstract] [Full Text] [Related]
29. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection. Dennehy PH, Saracen CL, Peter G. Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862 [Abstract] [Full Text] [Related]
30. Measles, mumps, and rubella antibodies in vaccinated Baltimore children. King JC, Lichenstein R, Feigelman S, Luna C, Permutt TJ, Patel J. Am J Dis Child; 1993 May; 147(5):558-60. PubMed ID: 8488803 [Abstract] [Full Text] [Related]
31. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Christenson B, Böttiger M. Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093 [Abstract] [Full Text] [Related]
35. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age. Gatchalian S, Cordero-Yap L, Lu-Fong M, Soriano R, Ludan A, Chitour K, Bock HL. Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661 [Abstract] [Full Text] [Related]
36. Response to measles-mumps-rubella vaccine in children on dialysis. Schulman SL, Deforest A, Kaiser BA, Polinsky MS, Baluarte HJ. Pediatr Nephrol; 1992 Mar; 6(2):187-9. PubMed ID: 1571219 [Abstract] [Full Text] [Related]
37. Expression of interleukin-2 receptor alpha and CD45RO antigen on T lymphocytes cultured with rubella virus antigen, compared with humoral immunity in rubella vaccinees. Toyoda M, Ihara T, Nakano T, Ito M, Kamiya H. Vaccine; 1999 Apr 09; 17(15-16):2051-8. PubMed ID: 10217606 [Abstract] [Full Text] [Related]